Open Source Pharma
  • Home
    • Why We Need OSP >
      • Articles
      • Group Blog >
        • Initiatives >
          • Open Source Malaria
          • Nipah Virus Open Research Collaborative
          • All
  • Who We Are
    • Vision & Mission
    • This Website
  • Conferences
    • Paris 2019 >
      • OSP3 Application Form
    • Past Conferences >
      • Germany
      • Bellagio
  • Forum
  • Resources
  • Get Involved

CONFERENCES

OSP3 - PARIS 2019
The 3rd Open Source Pharma Conference
Science, License, Community

​
Center for Research and Interdisciplinarity (CRI)
​March 21st, 2pm CET - March 23rd, 11:30am CET
University of Paris, France
Join the online discussion
Download one-pager
Download two-pager

Affordable medicine is a grand challenge of our time.

OSP3 will be a singular gathering of researchers, entrepreneurs, industry professionals, funders and NGOs and who want to achieve radical improvements in the way we deliver therapeutics to market in the 21st century.

Open source brings the promise of efficient, robust and inclusive routes to discovery. While great progress has been made in opening up the discovery and development of new medicines, there remain major barriers to open source medicines reaching patients. Our task in this meeting is to learn about and spark new initiatives, to understand the main challenges together and to propose new, realistic solutions for implementation.
This meeting follows the 1st OSP conference, which took place at the Bellagio Center, Lake Como, Italy in 2014, and the second, which took place at Castle Rauischholzhausen, Marburg, Germany in 2015. Partners and sponsors have included The Rockefeller Foundation, Open Society Foundations and Tata Trusts. The OSP3 meeting is sponsored by CRI Research.
Picture
Picture
Interested in attending? Fill out an application!

Number of Attendees: small (<50) select group of the world's thought leaders, feeding significant “live” social media outreach

Committed Participants include:
  • Mostapha Benhenda (Founder, Startcrowd, San Francisco)
  • Anneke Blackburn (Australian National University, Canberra)
  • Bruce Bloom (CEO, Cures Within Reach, Chicago)
  • Adrian Bradley (Partner, Cleveland Scott York, London)
  • Samir Brahmachari (Founder, OSDD; ex-Director General, CSIR, Delhi)
  • Keith Elliston (i2b2/tranSMART, Boston)
  • Stephen Friend (Chair, Sage Bionetworks; ex senior VP, Merck, Seattle)
  • Nicole Foti (Open Insulin Project, San Francisco)
  • Lee Hartwell (Nobel Laureate; Arizona State University, Arizona) (by video)
  • Richard Gold (Founding Director, Centre for Intellectual Property Policy, McGill University, Montreal) 
  • Linda Kahl (Senior Counsel & Director of Ownership and Innovation, BioBricks, San Francisco)
  • Peter Kolb (Philipps University-Marburg, Marburg)
  • Ariel Lindner (Co-founder, CRI - Centre de Recherches Interdisciplinaires, Paris)
  • Jaykumar Menon (Harvard University, Boston; OSPF, Bangalore)
  • Bernard Munos (FasterCures; Forbes; ex-Eli Lilly, Indiana)
  • Bose Natarajan (Science Advisor, Bill Gates; bgC3/Gates Ventures, Seattle)
  • Shailesh Nayak (Director, National Institute for Advanced Studies, Delhi)
  • Ganesh Neelam (Tata Trusts, Mumbai)
  • Niclas Nilsson (LEO Pharma, Ballerup)
  • Ole Oleson (European & Developing Countries Clinical Trials Partnership, Amsterdam)
  • Ochoro Otunnu (Founder, Africa Aids Initiative, Africa Center for Democracy, New York)
  • Benjamin Perry (Senior Discovery Manager, Drugs for Neglected Diseases Initiative, Geneva)
  • Arti Rai (Duke Law School, North Carolina)
  • Allison Randal (former President, Open Source Initiative, London)
  • Guy Rouleau (Director, Montreal Neurological Institute and Hospital, McGill University, Montreal)
  • Tomasz Sablinski (CEO, Transparency Life Sciences, New York)
  • Jack Scannell (GoldLab Foundation, Oxford)
  • Vinod Scaria (Council of Scientific & Industrial Research, Bangalore)
  • William Scott (Professor, IUPUI - Indiana University-Purdue University Indianapolis, Indiana) 
  • Sitta Sittampalam (Senior Advisor, NCATS - National Center for Advancing Translational Sciences, Maryland)
  • Geoffrey Siwo (University of Notre Dame, Indiana)
  • Ellen t'Hoen (MSF - Médecins Sans Frontières, Amsterdam)
  • Zelalem Temesgen (Head, Mayo Clinic Center for Tuberculosis, Minnesota)
  • Matthew Todd (University College London; Founder, Open Source Malaria, London)​
  • Andy Updegrove (Legal Counsel, Linux Foundation)
  • John Wilbanks (Sage Bionetworks, Seattle)
  • Alice Williamson (University of Sydney, Sydney)
​Partners and Sponsors: CRI-Paris, Cures Within Reach, Open Source Malaria, European & Developing Countries Clinical Trials Partnership, Tata Trusts, Philipps-University Marburg, Open Source Pharma Foundation, Sage Bionetworks, Mayo Clinic TB Center

Venue: The newly renovated building of CRI, a global leader in open science and quantitative approaches to biology, situated in the heart of Paris.
​

Organizing Contacts:​​
Wengsi Chiu (Open Source Pharma,
weng-si.chiu@mail.mcgill.ca)
Alina Grenier-Arellano (Open Sournce Pharma, alina.grenierarellano@mail.mcgill.ca)

Peter Kolb (University of Marburg,
peter.kolb@uni-marburg.de)

Ariel Lindner (CRI, ariel.lindner@inserm.fr)
Jaykumar Menon (Harvard University,

​jmenon@hsph.harvard.edu)
Matthew Todd (University College London,
matthew.todd@ucl.ac.uk)

​Previous Conferences:
GERMANY 2015
BELLAGIO 2014

Interested in joining OSP3?

FILL OUT AN APPLICATION
Join the online discussion
Download two-pager
Stay up to date

​Who We Are
Vision & Mission Statement
About this Site
Why We Need OSP
Group Blog

Initiatives
​Conferences
Forum
Resources

Get Involved
Contact Us:
info@opensourcepharma.net
Nodes of Activity:
Bangalore - Boston - Chicago - Kozhikode - ​London - Marburg - Montreal - Mumbai - New York - Paris - Toronto - San Francisco
  • Home
    • Why We Need OSP >
      • Articles
      • Group Blog >
        • Initiatives >
          • Open Source Malaria
          • Nipah Virus Open Research Collaborative
          • All
  • Who We Are
    • Vision & Mission
    • This Website
  • Conferences
    • Paris 2019 >
      • OSP3 Application Form
    • Past Conferences >
      • Germany
      • Bellagio
  • Forum
  • Resources
  • Get Involved